BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 32606208)

  • 1. Global burden of oesophageal and gastric cancer by histology and subsite in 2018.
    Arnold M; Ferlay J; van Berge Henegouwen MI; Soerjomataram I
    Gut; 2020 Sep; 69(9):1564-1571. PubMed ID: 32606208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global patterns of cardia and non-cardia gastric cancer incidence in 2012.
    Colquhoun A; Arnold M; Ferlay J; Goodman KJ; Forman D; Soerjomataram I
    Gut; 2015 Dec; 64(12):1881-8. PubMed ID: 25748648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997.
    Orengo MA; Casella C; Fontana V; Filiberti R; Conio M; Rosso S; Tumino R; Crosignani P; De Lisi V; Falcini F; Vercelli M;
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):739-46. PubMed ID: 16772831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007.
    Schmassmann A; Oldendorf MG; Gebbers JO
    Eur J Epidemiol; 2009; 24(10):603-9. PubMed ID: 19669623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global incidence of oesophageal cancer by histological subtype in 2012.
    Arnold M; Soerjomataram I; Ferlay J; Forman D
    Gut; 2015 Mar; 64(3):381-7. PubMed ID: 25320104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998.
    Newnham A; Quinn MJ; Babb P; Kang JY; Majeed A
    Aliment Pharmacol Ther; 2003 Mar; 17(5):665-76. PubMed ID: 12641515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.
    Arnold M; Colquhoun A; Cook MB; Ferlay J; Forman D; Soerjomataram I
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):90-7. PubMed ID: 26494763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time.
    Li M; Park JY; Sheikh M; Kayamba V; Rumgay H; Jenab M; Narh CT; Abedi-Ardekani B; Morgan E; de Martel C; McCormack V; Arnold M
    Gut; 2023 May; 72(5):846-854. PubMed ID: 36241389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent incidence trends of oesophago-gastric cancer in Sweden.
    Abdulkarim D; Mattsson F; Lagergren J
    Acta Oncol; 2022 Dec; 61(12):1490-1498. PubMed ID: 36594265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.
    Feller A; Fehr M; Bordoni A; Bouchardy C; Frick H; Mousavi M; Steiner A; Arndt V; Clough-Gorr KM;
    Swiss Med Wkly; 2015; 145():w14245. PubMed ID: 26661828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuing rising trend in oesophageal adenocarcinoma.
    Powell J; McConkey CC; Gillison EW; Spychal RT
    Int J Cancer; 2002 Dec; 102(4):422-7. PubMed ID: 12402314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
    Morgan E; Soerjomataram I; Rumgay H; Coleman HG; Thrift AP; Vignat J; Laversanne M; Ferlay J; Arnold M
    Gastroenterology; 2022 Sep; 163(3):649-658.e2. PubMed ID: 35671803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional and national burden of primary liver cancer by subtype.
    Rumgay H; Ferlay J; de Martel C; Georges D; Ibrahim AS; Zheng R; Wei W; Lemmens VEPP; Soerjomataram I
    Eur J Cancer; 2022 Jan; 161():108-118. PubMed ID: 34942552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in oesophago-gastric cancer incidence in Spain: analysis by subsite and histology.
    Aragonés N; Izarzugaza MI; Ramos M; Chirlaque MD; Almar E; Martínez C;
    Ann Oncol; 2010 May; 21 Suppl 3():iii69-75. PubMed ID: 20427363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study.
    Koppert LB; Janssen-Heijnen ML; Louwman MW; Lemmens VE; Wijnhoven BP; Tilanus HW; Coebergh JW
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):681-8. PubMed ID: 15201582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology.
    Dolan K; Sutton R; Walker SJ; Morris AI; Campbell F; Williams EM
    Br J Cancer; 1999 May; 80(5-6):834-42. PubMed ID: 10360663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol, smoking and risk of oesophago-gastric cancer.
    Dong J; Thrift AP
    Best Pract Res Clin Gastroenterol; 2017 Oct; 31(5):509-517. PubMed ID: 29195670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.
    Wu X; Chen VW; Andrews PA; Ruiz B; Correa P
    Cancer Causes Control; 2007 Aug; 18(6):585-93. PubMed ID: 17406989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037.
    Offman J; Pesola F; Sasieni P
    Br J Cancer; 2018 May; 118(10):1391-1398. PubMed ID: 29563637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.